B. Hocker, L. Weber, T. Buncman, M. Rashford, and B. Tonshoff, Mycophenolate mofetil suspension in pediatric renal transplantation: Three-year data from the tricontinental trial, Pediatric Transplantation, vol.13, issue.4, pp.504-515, 2005.
DOI : 10.1111/j.1399-3046.2005.00335.x

U. Helmchen, B. Klare, G. Klaus, H. Leichter, M. Mihatsch et al., For the German Pediatric Renal Transplantation Study Group. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years, Transplantation, vol.75, pp.454-61, 2003.

D. Lirenman, L. Greenbaum, R. Walker, L. Zimmerhackl, D. Blowey et al., The use of mycophenolate mofetil suspension in pediatric renal allograft recipients, Pediatr Nephrol, vol.16, pp.978-84, 2001.

L. Zimmerhackl, Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group

L. Weber, M. Shipkova, V. Armstrong, N. Wagner, E. Schütz et al., The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy, J Am Soc Nephrol, vol.13, pp.759-68, 2002.

L. Weber, T. Lamersdorf, M. Shipkova, P. Niedmann, M. Wiesel et al., Area Under the Plasma Concentration???Time Curve for Total, But Not for Free, Mycophenolic Acid Increases in the Stable Phase After Renal Transplantation: A Longitudinal Study in Pediatric Patients, Therapeutic Drug Monitoring, vol.21, issue.5, pp.498-506, 1999.
DOI : 10.1097/00007691-199910000-00002

L. Weber, M. Shipkova, V. Armstrong, N. Wagner, E. Schütz et al., The pharmacokinetic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German Study Group on mycophenolate mofetil therapy, J Am Soc Nephrol, vol.13, pp.759-68, 2002.

L. Weber, B. Hoecker, V. Armstrong, M. Oellerich, and B. Tönshoff, Long-Term Pharmacokinetics of Mycophenolic Acid in Pediatric Renal Transplant Recipients Over 3 Years Posttransplant, Therapeutic Drug Monitoring, vol.30, issue.5, pp.570-575, 2008.
DOI : 10.1097/FTD.0b013e31818752d9

R. Van-hest, T. Van-gelder, R. Bouw, T. Goggin, R. Gordon et al., Time-dependent clearance of mycophenolic acid in renal transplant recipients, British Journal of Clinical Pharmacology, vol.41, issue.6, pp.741-52, 2007.
DOI : 10.1097/01.ftd.0000199358.80013.bd

A. Prémaud, J. Debord, A. Rousseau, L. Meur, Y. Toupance et al., A Double Absorption-Phase Model Adequately Describes Mycophenolic Acid Plasma Profiles in De Novo Renal Transplant Recipients Given Oral Mycophenolate Mofetil, Clinical Pharmacokinetics, vol.23, issue.6, pp.837-884, 2005.
DOI : 10.2165/00003088-200544080-00005

Z. Jiao, J. Ding, J. Shen, H. Liang, L. Zhong et al., Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9, British Journal of Clinical Pharmacology, vol.41, issue.6, pp.893-907, 2008.
DOI : 10.1253/circj.71.1022

B. Shum, S. Duffull, P. Taylor, and S. Tett, Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil, British Journal of Clinical Pharmacology, vol.22, issue.2, pp.188-97, 2003.
DOI : 10.1046/j.1365-2125.2003.01863.x

T. Funaki, Enterohepatic Circulation Model for Population Pharmacokinetic Analysis, Journal of Pharmacy and Pharmacology, vol.18, issue.10, pp.1143-1151, 1999.
DOI : 10.1211/0022357991776831

R. Verbeeck, Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus, Clin Pharmacokinet, vol.48, issue.11, pp.745-58, 2009.

L. Weber, B. Hoecker, V. Armstrong, M. Oellerich, and B. Tönshoff, Validation of an Abbreviated Pharmacokinetic Profile for the Estimation of Mycophenolic Acid Exposure in Pediatric Renal Transplant Recipients*, Therapeutic Drug Monitoring, vol.28, issue.5, pp.623-654, 2006.
DOI : 10.1097/01.ftd.0000246766.12872.12

G. Filler and I. Mai, Limited Sampling Strategy for Mycophenolic Acid Area Under the Curve, Therapeutic Drug Monitoring, vol.22, issue.2, pp.169-73, 2000.
DOI : 10.1097/00007691-200004000-00005

E. Schütz, V. Armstrong, M. Shipkova, L. Weber, P. Niedmann et al., Limited Sampling Strategy for the Determination of Mycophenolic Acid Area Under the Curve in Pediatric Kidney Recipients, Transplantation Proceedings, vol.30, issue.4, pp.1182-1186, 1998.
DOI : 10.1016/S0041-1345(98)00200-0

L. Hary, D. Debruyne, S. Saivin, E. Jacqz-aigrain, and P. Marquet, Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentrationcontrolled versus fixed-dose trial in renal transplant recipients, Pharmacol Res, vol.61, issue.2, pp.167-74, 2010.

P. Marquet, Cost-Effectiveness Analysis of Individualized Mycophenolate Mofetil Dosing in Kidney Transplant Patients in the APOMYGRE Trial, Transplantation, 2010.

E. Jacqz-aigrain, Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients, Ther Drug Monit, vol.27, pp.378-88, 2005.

C. Staatz, S. Duffull, B. Kiberd, A. Fraser, and S. Tett, Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation, European Journal of Clinical Pharmacology, vol.40, issue.7, pp.507-523, 2005.
DOI : 10.1007/s00228-005-0927-4

R. Van-hest, T. Van-gelder, A. Vulto, and R. Mathot, Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients, Clinical Pharmacokinetics, vol.43, issue.6, pp.1083-96, 2005.
DOI : 10.2165/00003088-200544100-00006

B. Winter, T. Van-gelder, P. Glander, D. Cattaneo, H. Tedesco-silva et al., Population Pharmacokinetics of Mycophenolic Acid, Clinical Pharmacokinetics, vol.27, issue.3, pp.827-865, 2008.
DOI : 10.2165/0003088-200847120-00007

W. Sam, F. Akhlaghi, and S. Rosenbaum, Population Pharmacokinetics of Mycophenolic Acid and Its 2 Glucuronidated Metabolites in Kidney Transplant Recipients, The Journal of Clinical Pharmacology, vol.34, issue.2, pp.185-95, 2009.
DOI : 10.1177/0091270008329558

K. Petersson, E. Hanze, R. Savic, and M. Karlsson, Semiparametric Distributions With Estimated Shape Parameters, Pharmaceutical Research, vol.16, issue.9, pp.2174-85, 2009.
DOI : 10.1007/s11095-009-9931-1

R. Leary, R. Jelliffe, A. Schumitzky, and M. Van-guilder, A unified parametric/nonparametric approach to population PK/PD modeling. Annual meeting of the Population Approach Group in Europe, 2002.

A. Schumitzky, The nonparametric maximum likelihood approach to pharmacokinetic population analysis Proceedings of the 1993 Western Simulation Multiconference-Simulation for health care. Society for computer simulation, pp.95-100, 1993.

A. Mallet, A maximum likelihood estimation method for random coefficient regression models, Biometrika, vol.73, issue.3, pp.645-56, 1986.
DOI : 10.1093/biomet/73.3.645

S. Beal, L. Sheiner, and A. Boeckmann, NONMEM user " s guides 1989-2006, Icon Development solutions

S. Urien, . Rfn, and . For-nonmen, A graphical interface for Nonmen outputs, 2009.

M. Karlsson and R. Savic, Diagnosing Model Diagnostics, Clinical Pharmacology & Therapeutics, vol.23, issue.1, pp.17-20, 2007.
DOI : 10.1038/sj.clpt.6100241

D. Argenio and A. Schumitzky, ADAPT II User " s guide, Pharmacokinetics/Pharmacodynamic Systems Analysis Software, Biomedical Simulations Resource, 1997.

R. Development and C. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2009.

W. Zhao, M. Fakhoury, G. Deschênes, G. Roussey, K. Brochard et al., Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal-Transplant Patients, The Journal of Clinical Pharmacology, vol.62, issue.182, pp.358-66, 2010.
DOI : 10.1177/0091270009357429

D. Hesselink, R. Van-hest, and R. Mathot, Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2, American Journal of Transplantation, vol.41, issue.1, pp.987-94, 2005.
DOI : 10.1046/j.1523-1755.2001.00782.x

T. Van-gelder, J. Klupp, M. Barten, U. Christians, and R. Morris, Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid, Therapeutic Drug Monitoring, vol.23, issue.2, pp.119-147, 2001.
DOI : 10.1097/00007691-200104000-00005

A. Bustad, D. Terziivanov, R. Leary, R. Port, A. Schumitzky et al., Parametric and Nonparametric Population Methods, Clinical Pharmacokinetics, vol.36, issue.4, pp.365-83, 2006.
DOI : 10.2165/00003088-200645040-00003